Med Life S.A. (BVB:M)
5.82
-0.10 (-1.69%)
At close: Mar 3, 2025
Med Life Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2020 - 2016 |
Operating Revenue | 2,715 | 2,210 | 1,795 | 1,427 | 1,077 | Upgrade
|
Other Revenue | 9.02 | 11.3 | 14.12 | 10.36 | 9.27 | Upgrade
|
Revenue | 2,724 | 2,222 | 1,810 | 1,438 | 1,087 | Upgrade
|
Revenue Growth (YoY) | 22.63% | 22.78% | 25.87% | 32.29% | 11.46% | Upgrade
|
Cost of Revenue | 1,393 | 1,160 | 977.47 | 674.49 | 502.66 | Upgrade
|
Gross Profit | 1,331 | 1,061 | 832.08 | 763.09 | 584.06 | Upgrade
|
Selling, General & Admin | 853.7 | 694.63 | 519.15 | 415.44 | 312.26 | Upgrade
|
Other Operating Expenses | 76.83 | 73.06 | 61.45 | 56.77 | 48.9 | Upgrade
|
Operating Expenses | 1,189 | 965.13 | 737.85 | 585.97 | 474.95 | Upgrade
|
Operating Income | 142.4 | 96.19 | 94.23 | 177.12 | 109.11 | Upgrade
|
Interest Expense | -101.17 | -76.31 | -34.32 | -21.6 | -23.25 | Upgrade
|
Interest & Investment Income | 2.48 | 3.42 | 1.26 | 0.15 | 0.05 | Upgrade
|
Currency Exchange Gain (Loss) | 0.14 | -9.69 | -4.08 | -9.17 | -9.94 | Upgrade
|
Other Non Operating Income (Expenses) | 0.46 | -4.64 | -7.53 | -5.82 | 2.59 | Upgrade
|
EBT Excluding Unusual Items | 44.32 | 8.97 | 49.56 | 140.69 | 78.55 | Upgrade
|
Merger & Restructuring Charges | - | -2.03 | - | - | - | Upgrade
|
Asset Writedown | - | -2.64 | - | -5.27 | - | Upgrade
|
Pretax Income | 44.32 | 4.3 | 49.56 | 135.42 | 78.55 | Upgrade
|
Income Tax Expense | 25.96 | 8.46 | 12.12 | 22.51 | 14.79 | Upgrade
|
Earnings From Continuing Operations | 18.36 | -4.16 | 37.43 | 112.91 | 63.76 | Upgrade
|
Minority Interest in Earnings | 7.19 | 7.85 | -5.26 | -10.3 | -7.06 | Upgrade
|
Net Income | 25.55 | 3.68 | 32.17 | 102.61 | 56.7 | Upgrade
|
Net Income to Common | 25.55 | 3.68 | 32.17 | 102.61 | 56.7 | Upgrade
|
Net Income Growth | 593.37% | -88.55% | -68.65% | 80.97% | 316.59% | Upgrade
|
Shares Outstanding (Basic) | 531 | 531 | 531 | 531 | 530 | Upgrade
|
Shares Outstanding (Diluted) | 531 | 531 | 531 | 531 | 530 | Upgrade
|
Shares Change (YoY) | -0.06% | 0.05% | -0.02% | 0.31% | 0.05% | Upgrade
|
EPS (Basic) | 0.05 | 0.01 | 0.06 | 0.19 | 0.11 | Upgrade
|
EPS (Diluted) | 0.05 | 0.01 | 0.06 | 0.19 | 0.11 | Upgrade
|
EPS Growth | 593.81% | -88.56% | -68.64% | 80.42% | 316.40% | Upgrade
|
Free Cash Flow | 46.81 | -17.81 | 35.51 | 135.87 | 45.55 | Upgrade
|
Free Cash Flow Per Share | 0.09 | -0.03 | 0.07 | 0.26 | 0.09 | Upgrade
|
Gross Margin | 48.87% | 47.77% | 45.98% | 53.08% | 53.75% | Upgrade
|
Operating Margin | 5.23% | 4.33% | 5.21% | 12.32% | 10.04% | Upgrade
|
Profit Margin | 0.94% | 0.17% | 1.78% | 7.14% | 5.22% | Upgrade
|
Free Cash Flow Margin | 1.72% | -0.80% | 1.96% | 9.45% | 4.19% | Upgrade
|
EBITDA | 391.7 | 210.35 | 183.71 | 245.58 | 175.34 | Upgrade
|
EBITDA Margin | 14.38% | 9.47% | 10.15% | 17.08% | 16.14% | Upgrade
|
D&A For EBITDA | 249.3 | 114.16 | 89.48 | 68.45 | 66.23 | Upgrade
|
EBIT | 142.4 | 96.19 | 94.23 | 177.12 | 109.11 | Upgrade
|
EBIT Margin | 5.23% | 4.33% | 5.21% | 12.32% | 10.04% | Upgrade
|
Effective Tax Rate | 58.58% | 196.87% | 24.47% | 16.62% | 18.83% | Upgrade
|
Revenue as Reported | 2,724 | 2,222 | 1,810 | 1,438 | 1,087 | Upgrade
|
Advertising Expenses | 49.19 | 37.02 | 26.66 | 15.14 | 13.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.